### ğŸ« Pulmonary Medicine: Acute Mountain Sickness Prophylaxis

#### âœ… True Statements
1. **Acute mountain sickness (AMS)** occurs with ascent to altitude due to lower barometric pressure and resultant hypobaric hypoxemia.
2. Symptoms of **acute mountain sickness** include **headache**, **fatigue**, **nausea**, and **sleep disruption**, and they typically resolve within **24 to 48 hours**.
3. Symptoms such as **mental status changes** and **dyspnea** are **not seen in acute mountain sickness** and should prompt consideration of **high-altitude cerebral edema** or **high-altitude pulmonary edema**.
4. **Acute mountain sickness** affects up to **25% of visitors** to elevations greater than **2000 meters (6562 feet)**.
5. **Gradual ascent**, avoidance of **heavy exertion**, and avoidance of **alcohol consumption** decrease the incidence and severity of **acute mountain sickness**.
6. **Acetazolamide** is effective in the **prevention of acute mountain sickness**.
7. **Adverse effects** of acetazolamide include **paresthesia** and **inability to sense carbonation** in carbonated beverages.
8. Persons who have had **acute mountain sickness before** and who are ascending to elevations above **2500 meters (8202 feet)** should be offered **prophylaxis with acetazolamide**, especially if **rapid ascent** is planned.
9. **Hydrochlorothiazide** has never been studied in **acute mountain sickness** and is **not indicated**.
10. **Ibuprofen** and **aspirin** may treat headache in **acute mountain sickness**, but they have **no proven role in prevention**.
11. **Nifedipine** can be used in prevention of **high-altitude pulmonary edema**, but it is **not indicated for prevention of acute mountain sickness**.

#### ğŸ’¬ Extra
2. Gastrointestinal symptoms such as **vomiting** may also accompany acute mountain sickness, but are nonspecific.
6. The mechanism by which acetazolamide accelerates acclimatization is unclear.
11. **High-altitude pulmonary edema** typically occurs at **altitudes >2500 meters**, usually **2 to 4 days** after arrival, distinguishing it from **acute mountain sickness**, which occurs within **hours**.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #AcuteMountainSickness #AltitudeIllness #Acetazolamide #AmbulatoryCare #Prevention

#### ğŸ“š Reference
Luks AM, Hackett PH. Medical conditions and high-altitude travel. *N Engl J Med*. 2022;386(4):364-73. PMID: 35081281 doi:10.1056/NEJMra2104829

#### ğŸ†” Question ID
PMMCQ24036

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP 19: Pulmonary Medicine â€” High Altitudeâ€“Related Illnesses, Acute Mountain Sickness

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements â€” Acute Mountain Sickness
1. **Acute mountain sickness** is the most common **high altitudeâ€“related illness**, affecting up to **25% of visitors** to altitudes of **2000 meters (6500 feet)**.
2. **Cerebral blood flow** and **oxygen delivery to the brain** are altered by **hypoxia** and **hypocapnia** during ascent to altitude.
3. **High-altitude periodic breathing** occurs when **hypoxia-sensitive chemoreceptors** increase ventilation, leading to **hypocapnia**, which drives arterial Pcoâ‚‚ below the apneic threshold and results in **central apnea**.
4. The cycle of **ventilatory overshoot**, **hypocapnia**, and **central apneas** repeats frequently at night at altitude.
5. **Symptoms of acute mountain sickness** are nonspecific and include **headache**, **fatigue**, **nausea**, and **vomiting**.
6. **High-altitude periodic breathing** can cause **interrupted sleep**, **insomnia**, and **paroxysms of dyspnea** that awaken individuals.
7. **Heavy exertion** and **dehydration** amplify symptoms of **acute mountain sickness**.
8. **Alcohol ingestion** worsens **high-altitude periodic breathing** by promoting **dehydration**.
9. In the absence of further ascent, symptoms of **acute mountain sickness** typically resolve within **24 to 48 hours**.

#### ğŸ’¬ Extra
3. Central apnea at altitude is due to the arterial Pcoâ‚‚ crossing the apneic threshold during overventilation.
6. **Paroxysms of dyspnea** are distinct from persistent dyspnea of **high-altitude pulmonary edema**.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #AcuteMountainSickness #AltitudeIllness #HighAltitudePhysiology #AmbulatoryCare

---

#### ğŸ–¼ï¸ Supplemental Figures
*(none)*

#### ğŸ—¾ Supplemental Tables

<!-- Spectrum Table -->
<table>
  <caption><strong>Characteristics of High Altitudeâ€“Related Illness Syndromes</strong></caption>
  <thead>
    <tr>
      <th>Illness</th>
      <th>Elevation Level</th>
      <th>Symptoms</th>
      <th>Treatment</th>
      <th>Prevention</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Acute mountain sickness</td>
      <td>2000 to 2500 m (6500 to 8200 ft)</td>
      <td>Nonspecific; headache, malaise, anorexia, nausea, vomiting</td>
      <td>Supplemental oxygen, acetazolamide, dexamethasone, descent from altitude; aspirin or NSAID for headache</td>
      <td>Gradual ascent (&lt;500 m/d [1600 ft/d]) at high altitude; prophylaxis with acetazolamide or dexamethasone for rapid ascent or in patients at high risk</td>
    </tr>
    <tr>
      <td>High-altitude cerebral edema</td>
      <td>3000 to 4000 m (10,000 to 13,000 ft)</td>
      <td>Confusion, irritability, ataxic gait, coma, death</td>
      <td>Descent from altitude, dexamethasone, supplemental oxygen, hyperbaric therapy</td>
      <td>Gradual ascent; consider acetazolamide or dexamethasone in patients at high risk</td>
    </tr>
    <tr>
      <td>High-altitude pulmonary edema</td>
      <td>&gt;2500 m (&gt;8200 ft)</td>
      <td>Cough, exertional intolerance, dyspnea at rest, frothy sputum (2â€“4 d after arrival at new altitude)</td>
      <td>Supplemental oxygen and descent from altitude; adjunctive therapy: nifedipine, phosphodiesterase-5 inhibitors; diuretics and nitrates not recommended; intubation may be required</td>
      <td>Gradual ascent; consider nifedipine in patients at high risk</td>
    </tr>
  </tbody>
</table>

#### âœ… True Statements (from Table: Characteristics of High Altitudeâ€“Related Illness Syndromes)
1. **Acute mountain sickness** can be treated with **supplemental oxygen**, **acetazolamide**, **dexamethasone**, and **descent from altitude**, and **aspirin or a nonsteroidal anti-inflammatory drug (NSAID)** may be used for associated **headache**.
2. **Prevention of acute mountain sickness** includes **gradual ascent** (less than **500 meters per day**) and **prophylaxis with acetazolamide or dexamethasone** for **rapid ascent** or in individuals at **high risk**.
3. **High-altitude cerebral edema (HACE)** presents with **confusion**, **irritability**, **ataxic gait**, and may progress to **coma** and **death** at **3000 to 4000 meters (10,000 to 13,000 feet)**.
4. Treatment of **high-altitude cerebral edema** includes **descent from altitude**, **dexamethasone**, **supplemental oxygen**, and **hyperbaric therapy**.
5. **High-altitude pulmonary edema (HAPE)** typically occurs at **altitudes greater than 2500 meters (8200 feet)** and presents with **cough**, **exertional intolerance**, **dyspnea at rest**, and **frothy sputum** **2 to 4 days** after arrival at a new altitude.
6. Treatment of **high-altitude pulmonary edema** includes **supplemental oxygen** and **descent from altitude** with **adjunctive therapy** such as **nifedipine** or **phosphodiesteraseâ€‘5 inhibitors**; **diuretics** and **nitrates** are **not recommended**, and **intubation may be required**.
7. **Prevention of high-altitude pulmonary edema** includes **gradual ascent** and **consideration of nifedipine** in **highâ€‘risk** individuals.

#### ğŸ’¬ Extra (from Table)
2. The **<500 m/day** ascent guideline corresponds to approximately **1600 ft/day**.
5. The **2â€“4 day** delay in **high-altitude pulmonary edema** onset contrasts with the **within-hours** onset of **acute mountain sickness**.

#### ğŸ·ï¸ Tags
#HighAltitudeIllness #AMS #HACE #HAPE #Dexamethasone #Nifedipine #PDE5Inhibitors #Prevention #SupplementalOxygen #HyperbaricTherapy

---

#### ğŸ”Š Supplemental Videos
*(none)*